Page last updated: 2024-09-03

n-acetylneuraminoyllactose and 2019 Novel Coronavirus Disease

n-acetylneuraminoyllactose has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Channappanavar, R; He, P; Linhardt, RJ; Song, Y; Tandon, R; Xia, K; Zhang, F	1

Other Studies

1 other study(ies) available for n-acetylneuraminoyllactose and 2019 Novel Coronavirus Disease

Article	Year
Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin. International journal of biological macromolecules, 2023, Aug-15, Volume: 246 Topics: Animals; Antiviral Agents; Cattle; COVID-19; Dendrimers; Hemagglutinins; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2023

Article

Year

Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin.

International journal of biological macromolecules, 2023, Aug-15, Volume: 246

Topics: Animals; Antiviral Agents; Cattle; COVID-19; Dendrimers; Hemagglutinins; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2023